Silva, AugustoFonseca, João EuricoFinzel, Stephanie2024-04-162024-04-162024Front Med (Lausanne). 2024 Mar 28:11:1402043http://hdl.handle.net/10451/64334Copyright © 2024 Silva, Fonseca and Finzel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Scientific progress in any field of medicine, and rheumatology is no exception, is based on experimentation followed by the publication of accurate and reliable results. To achieve these aims, well-designed clinical studies need to be carried out, in such a way that other researchers can replicate them, as well as through a process of strict peer review of scientific journals. With the sustained observed expansion of journal publications in the rheumatology field, it becomes imperative to ensure the quality of published studies and results. This Research Topic consists of three papers—two review the reproducibility and rigor research, one in antinuclear antibodies (ANA) testing in pediatric practice and the second in general rheumatology field, while the third addresses the health-related misinformation issues on social media.engAntinuclear antibodyMisinformationReproducibilityScientific studiesTechnological developmentjournal article10.3389/fmed.2024.14020432296-858X